Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | THRA | P10827 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 4/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17183156 | 0.98 | HDAC1 (0.53) | HDAC1THRATHRBALDH1A1MAPT | |
| SCHEMBL9125569 | 0.95 | ALDH1A1 (0.52) | HDAC1THRATHRBALDH1A1MAPT | |
| SCHEMBL28251464 | 0.93 | HDAC1 (0.62) | HDAC1ALDH1A1MAPTRXFP1HDAC8 | |
| SCHEMBL5433433 | 0.87 | TDP1 (0.58) | HDAC1ALDH1A1MAPTCES2CES1 | |
| SCHEMBL27786791 | 0.87 | THRA (0.50) | HDAC1THRATHRBMAPTHDAC8 | |
| SCHEMBL14772981 | 0.86 | CYP4A11 (0.56) | HDAC1ALDH1A1MAPTRXFP1HDAC8 | |
| SCHEMBL23014696 | 0.84 | RARB (0.66) | THRATHRBALDH1A1MAPTTDP1 | |
| SCHEMBL11239422 | 0.84 | RARB (0.66) | THRATHRBALDH1A1MAPTTDP1 | |
| SCHEMBL17183142 | 0.84 | HDAC1 (0.54) | HDAC1THRATHRBALDH1A1MAPT | |
| SCHEMBL5539425 | 0.84 | HDAC1 (0.54) | HDAC1THRATHRBALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961401-B2 | UV cured benzophenone terminated quaternary ammonium antimicrobials for surfaces | NANO SAFE COATINGS INCORPORATED (US) | 2021-03-30 | — | — | US | disclosed |
| EP-2931702-B1 | UV CURED BENZOPHENONE TERMINATED QUATERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES | NANO SAFE COATINGS INCORPORATED (US) | 2019-02-20 | — | — | EP | disclosed |
| US-20180127598-A1 | UV CURED BENZOPHENONE TERMINATED QUATERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES | NANO SAFE COATINGS, LLC | 2018-05-10 | — | — | US | disclosed |
| US-20150299475-A1 | UV CURED BENZOPHENONE TERMINATED QUARTERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES | BIOSHIELD TECHNOLOGIES CANADA LIMITED (CA) | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961401-B2 | UV cured benzophenone terminated quaternary ammonium antimicrobials for surfaces | AAAS, UBE2M, UBE2I | HDAC1 247/4885THRA 4547/4885THRB 4685/4885 |
| US-20150299475-A1 | UV CURED BENZOPHENONE TERMINATED QUARTERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES | UBE2I, PHB1, AAAS | HDAC1 328/4885THRA 4634/4885THRB 4712/4885 |
| US-20180127598-A1 | UV CURED BENZOPHENONE TERMINATED QUATERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES | AAAS, UBE2M, UBE2I | HDAC1 247/4885THRA 4547/4885THRB 4685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.